Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Orciprenaline sulfate |
Is a |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Metaproterenol measurement |
Component |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Poisoning by metaproterenol |
Causative agent (attribute) |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Accidental orciprenaline poisoning |
Causative agent (attribute) |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Intentional orciprenaline poisoning (disorder) |
Causative agent (attribute) |
False |
Orciprenaline |
Inferred relationship |
Some |
|
intoxication par l'orciprénaline d'intention indéterminée |
Causative agent (attribute) |
False |
Orciprenaline |
Inferred relationship |
Some |
1 |
Orciprenaline adverse reaction (disorder) |
Causative agent (attribute) |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Allergy to metaproterenol |
Causative agent (attribute) |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Orciprenaline sulfate [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Orciprenaline sulfate 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Orciprenaline sulfate [obstetric use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Product containing orciprenaline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Metaproterenol inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Orciprenaline 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Metaproterenol 20mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Product containing orciprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Accidental orciprenaline poisoning |
Causative agent (attribute) |
True |
Orciprenaline |
Inferred relationship |
Some |
2 |
Intentional orciprenaline poisoning (disorder) |
Causative agent (attribute) |
True |
Orciprenaline |
Inferred relationship |
Some |
2 |
Product containing orciprenaline in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
|
Allergy to metaproterenol |
Causative agent (attribute) |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Orciprenaline |
Inferred relationship |
Some |
1 |
Orciprenaline 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline |
Inferred relationship |
Some |
1 |
Orciprenaline 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Orciprenaline sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Orciprenaline |
Inferred relationship |
Some |
|
Orciprenaline 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Orciprenaline |
Inferred relationship |
Some |
1 |
Product containing orciprenaline in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Product containing only orciprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Orciprenaline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |
Orciprenaline only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orciprenaline |
Inferred relationship |
Some |
1 |